EP 2049093 A2 20090422 - PHARMACEUTICAL COMPOSITION CONTAINING SAREDUTANT AND A SELECTIVE INHIBITOR OF SEROTONIN RECAPTURE OR AN INHIBITOR OF SEROTONIN/NOREPINEPHRINE RECAPTURE IN COMBINATION
Title (en)
PHARMACEUTICAL COMPOSITION CONTAINING SAREDUTANT AND A SELECTIVE INHIBITOR OF SEROTONIN RECAPTURE OR AN INHIBITOR OF SEROTONIN/NOREPINEPHRINE RECAPTURE IN COMBINATION
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT SAREDUTANT UND EINEM SELEKTIVEN SEROTONIN-WIEDERAUFNAHMEHEMMER ODER EINEM KOMBINIERTEN SEROTONIN-/NOREPINEPHRIN-WIEDERAUFNAHMEHEMMER
Title (fr)
COMPOSITION PHARMACEUTIQUE CONTENANT EN ASSOCIATION LE SAREDUTANT ET UN INHIBITEUR SELECTIF DE LA RECAPTURE DE LA SEROTONINE OU UN INHIBITEUR DE LA RECAPTURE DE LA SEROTONINE/NOREPINEPHRINE
Publication
Application
Priority
- FR 2007001314 W 20070730
- FR 0607050 A 20060731
- FR 0700863 A 20070207
Abstract (en)
[origin: US2008033014A1] A subject-matter of the present invention is pharmaceutical compositions comprising, in combination, at least one active ingredient chosen from (S)-(-)-N-[4-(4-acetamido-4-phenylpiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide and pharmaceutically acceptable salts there and at least one second active ingredient chosen from selective serotonin reuptake inhibitors, serotonin/norepinephrine reuptake inhibitors and pharmaceutically acceptable salts thereof.
IPC 8 full level
A61K 31/135 (2006.01); A61K 31/15 (2006.01); A61K 31/165 (2006.01); A61K 31/343 (2006.01); A61K 31/381 (2006.01); A61K 31/4468 (2006.01); A61K 31/4525 (2006.01); A61P 25/00 (2006.01)
CPC (source: EP KR US)
A61K 31/135 (2013.01 - EP KR US); A61K 31/15 (2013.01 - EP US); A61K 31/343 (2013.01 - EP KR US); A61K 31/4468 (2013.01 - EP US); A61K 31/451 (2013.01 - KR); A61K 31/4525 (2013.01 - EP US); A61P 15/00 (2017.12 - EP); A61P 15/08 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/18 (2017.12 - EP); A61P 25/22 (2017.12 - EP); A61P 25/24 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
See references of WO 2008017753A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
US 2008033014 A1 20080207; AR 062142 A1 20081015; AU 2007283530 A1 20080214; BR PI0714862 A2 20130702; CA 2658614 A1 20080214; CL 2007002217 A1 20080307; CO 6150152 A2 20100420; CR 10579 A 20090320; EA 200970167 A1 20090828; EC SP099093 A 20090227; EP 2049093 A2 20090422; GT 200900018 A 20100823; IL 196570 A0 20091118; JP 2009545573 A 20091224; KR 20090034368 A 20090407; MA 30645 B1 20090803; MX 2009001219 A 20090213; NO 20090924 L 20090318; PE 20080431 A1 20080526; TN 2009000008 A1 20100819; TW 200817003 A 20080416; US 2009227632 A1 20090910; UY 30517 A1 20080229; WO 2008017753 A2 20080214; WO 2008017753 A3 20090219
DOCDB simple family (application)
US 83032507 A 20070730; AR P070103357 A 20070730; AU 2007283530 A 20070730; BR PI0714862 A 20070730; CA 2658614 A 20070730; CL 2007002217 A 20070730; CO 09007492 A 20090128; CR 10579 A 20090121; EA 200970167 A 20070730; EC SP099093 A 20090127; EP 07823369 A 20070730; FR 2007001314 W 20070730; GT 200900018 A 20090731; IL 19657009 A 20090118; JP 2009522301 A 20070730; KR 20097002031 A 20090130; MA 31638 A 20090213; MX 2009001219 A 20070730; NO 20090924 A 20090227; PE 2007000979 A 20070726; TN 2009000008 A 20090114; TW 96126788 A 20070723; US 46921509 A 20090520; UY 30517 A 20070731